-
Product Insights
New![]()
Net Present Value Model: Teva Pharmaceutical Industries Ltd’s Uzedy
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Teva Pharmaceutical Industries Ltd’s Ustekinumab Biosimilar
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Teva Pharmaceutical Industries Ltd’s Aflibercept Biosimilar
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Teva Pharmaceutical Industries Ltd’s Omalizumab Biosimilar
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Teva Pharmaceutical Industries Ltd’s Denosumab Biosimilar
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. Teva Pharmaceutical Industries Ltd's Denosumab Biosimilar Drug Details: Denosumab biosimilar (TVB-009) is under development for treatment of post menopausal osteoporosis. The therapeutic candidate is...
-
Product Insights
New![]()
Net Present Value Model: Teva Pharmaceutical Industries Ltd’s Golimumab Biosimilar
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. Teva Pharmaceutical Industries Ltd's Golimumab Biosimilar Drug Details: Monoclonal antibody is under development for the treatment of inflammation, rheumatoid arthritis and musculoskeletal diseases. The...
-
Company Profile
![]()
Teva Pharmaceutical Industries Ltd – Company Profile
Teva Pharmaceutical Industries Ltd (Teva) discovers, develops, manufactures, and commercializes generic and specialty medicines. The company provides specialty medicines to treat disorders of the central nervous system (CNS), cancer, respiratory, dermatology, women’s health, and other disease conditions. It offers generic medicines in a range of dosage forms including capsules, tablets, injectables, liquids, inhalants, creams, and ointments. Teva also provides over-the-counter (OTC) products, besides active pharmaceutical ingredients (APIs). It also focuses on developing generic drugs. The company conducts its worldwide operations...
Add to Basket -
Product Insights
NewNeedle Free Injections Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Needle Free Injections Pipeline Market Report Overview Needle free Injections are devices that do not use a needle to administer medication. The Needle Free Injections pipeline market research report provides comprehensive information about the Needle Free Injections pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Territories ·      The US ·      Europe ·      Mexico ·      The UK ·      Canada ·      Costa Rica ·      El...
-
Product Insights
NewReflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trials Market Report Overview The Reflux Esophagitis (Gastroesophageal Reflux Disease) clinical trial market research report provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease) clinical trials scenario. This report provides top-line data relating to the clinical trials on Reflux Esophagitis and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7),...
-
Product Insights
NewAutism Spectrum Disorder (ASD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Autism Spectrum Disorder (ASD) Clinical Trials Market Report Overview The Autism Spectrum Disorder (ASD) clinical trial market research report provides an overview of the Autism Spectrum Disorder (ASD) clinical trials scenario. This report provides top-line data relating to the clinical trials on ASD and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TEV-56248 in Asthma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TEV-56248 in AsthmaDrug Details:TEV-56248 is under development for the treatment of asthma.Report CoverageThe data is segmented...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Olanzapine ER in Schizophrenia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Olanzapine ER in SchizophreniaDrug Details:Olanzapine ER (TV-44749) is under development for the treatment of schizophrenia. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TEV-53408 in Celiac Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TEV-53408 in Celiac DiseaseDrug Details:TEV-53408 is under development for the treatment of Celiac disease. It acts...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TEV-44749 in Schizophrenia
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TEV-44749 in Schizophrenia Drug Details: TV-44749 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TV-46046 in Female Contraception
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDataÂ’s proprietary machine learning algorithms developed using over 10 years of historical data. TV-46046 in Female Contraception Drug Details: TV-46046 is under development for producing contraceptive effect....
-
Product Insights
Teva Pharmaceutical Industries Ltd Pipeline Insight and Competitive Landscape, 2023
Teva Pharmaceutical Industries Ltd (Teva) discovers, develops, manufactures, and commercializes generic and specialty medicines. The company provides specialty medicines to treat disorders of the central nervous system (CNS), cancer, respiratory, dermatology, women’s health, and other disease conditions. It offers generic medicines in a range of dosage forms including capsules, tablets, injectables, liquids, inhalants, creams, and ointments. Teva also provides over-the-counter (OTC) products, besides active pharmaceutical ingredients (APIs). It focuses on developing new generic drugs. The company conducts its worldwide operations...
-
Product Insights
Teva Pharmaceuticals USA Inc Pipeline Insight and Competitive Landscape, 2023
Teva Pharmaceuticals USA Inc (Teva USA), a subsidiary of Teva Pharmaceutical Industries Ltd, develops, manufactures and supplies generic drugs, specialty pharmaceuticals, and active pharmaceutical ingredients. The company offers its products in the form of tablets, capsules, creams, ointments, gels, oral suspension, injections and syrups. It also produces biopharmaceuticals and biosimilars to treat pain, central nervous system, respiratory, and oncology indications. The company markets its products under Acanya, Adenoscan, Amoxil, Bentyl, Carafate, Depo-Medrol, Flolan, Levitra, Lidex and other brands. Teva USA...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Denosumab Biosimilar in Post Menopausal Osteoporosis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Denosumab Biosimilar in Post Menopausal Osteoporosis Drug Details: Denosumab biosimilar (TVB-009) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – anti-KRAS G12D mTCR PBL in Metastatic Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Anti-Kras G12D Mtcr Pbl in Metastatic Colorectal Cancer Drug Details:Gene therapy is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TEV-48574 in Ulcerative Colitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TEV-48574 in Ulcerative Colitis Drug Details: TEV-48574 is under development for the treatment of inflammatory...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.